Sector Alpha Week of 2026-08-05
Sector Alpha — machine-written from the numbers · Data as of 2026-08-05

Willdan Group, Inc.

WLDN
Industrials · Engineering & Construction

Willdan Group, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

The sharpest disagreement: annual EPS moved +120.9% against a −8.9% price move — the market has not yet caught up with the delivery.

The price is between stages while the P/E sits at the 12th percentile of its own 1-year range. Underneath, the last four quarters read mixed, and 238% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.

Stage
Mixed
partial read
Price
$76.5
−8.9% 1Y
P/E
20.7×
12th pctile
of its own 1-year range
Revenue (Apr 26)
$0.2 B
+6.7% YoY
Profit (Apr 26)
$0.0 B
Operating margin
6.3%
−0.4 pp YoY
ROE
20%
FY26
ROIC
13.5%
vs WACC 10.3% → +3.2 pp
Cash conversion
238%
of profit, last 3 FY
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Willdan Group, Inc. trades at $76.5, between stages. That is −18.4% against its own 200-day average. It sits at 12% of a 52-week range of $69 to $134. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (7 weeks and counting).

Today the stock is between stages. At $76.5 it trades −18.4% versus its 200-day average and sits at 12% of its 52-week range ($69–$134).

Aug 26: $76.5 Weekly closing price ($) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 1-year window.
−18.4% versus the 200-day line, week — of stage —
Price50-day avg200-day avg
$139$120$101$82.2$63.3$$77$94Jul 25Oct 25Jan 26May 26Aug 26
$139$120$101$82.2$63.3$$77$94Jul 25Jan 26Aug 26
Beating or trailing, week by week since 2025 Each cell is one week from 2025 to now (57 weeks): the stock's trailing 13-week return minus the S&P 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the S&P 500 reading is not held.
trailing 13-week return vs the S&P 500
Jul 25Aug 26

Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved +4% while the S&P 500 moved +24% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (7 weeks and counting; last ahead the week of 2026-06-18) — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.

Willdan Group, Inc. trades at 20.7× P/E, near the bottom of its own range — cheaper only 12% of the time. Its long-run median P/E is 32.8×, measured across 1.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 20.7× is near the bottom of its own range — cheaper only 12% of the time, against a long-run median of 32.8× measured over 1.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

One caveat before moving on: margins are the best this company has ever printed — cheap against its own history on record margins is not the same thing as cheap. If profitability mean-reverts, today's multiple is higher than it looks.

P/E 20.7× vs a 32.8× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly step line (right axis). 1.1-year window; loss-period spikes above 47× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
near the bottom of its own range — cheaper only 12% of the time
P/EMedianEPS (TTM) (quarterly)
49.6×$4.041.2×$3.032.9×$2.024.5×$1.016.2×$0.0×$20.63×$4Jul 25Oct 25Jan 26May 26Aug 26
49.6×$4.041.2×$3.032.9×$2.024.5×$1.016.2×$0.0×$20.63×$4Jul 25Jan 26Aug 26
PEG 10.51 PEG ratio per quarter — the P/E divided by the earnings-growth rate. The dashed line marks 1.0: below it the growth is cheap against the multiple, above it the price already prices the growth in. Last 19 quarters; values above 6 pinned at the top.
above 1.0, the multiple already banks the growth
PEGPEG = 1.0
6.4×5.0×3.5×2.0×0.6××6.00×Oct 21Sep 22Dec 23Dec 24Apr 26
6.4×5.0×3.5×2.0×0.6××6.00×Oct 21Dec 23Apr 26
P/E
20.7×
12th percentile of 1y
PEG
n/m
not derivable — 3-year earnings growth unavailable

Why the multiple sits where it does: over the past year annual EPS moved +120.9% against a −8.9% price move — earnings outran the price, pushing the multiple DOWN its own range.

Put together: the multiple is low against its own past, so the story rests on the earnings line underneath it, not the multiple.

03 · Stage: Mixed

Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Willdan Group, Inc. reads as mixed on its fundamental arc. Mixed — the growth curves are steadily positive, but ROCE at 11.0% is below the 15% bar this page requires to call it Consistent. The read is built from 12 quarters across 3 curves, on partial evidence.

Growth, year by year: revenue +19.3% in FY26, profit +150.0% Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
24%154%21%139%17%124%14%109%11%93%%%19.3%150%FY21FY23FY26
24%154%21%139%17%124%14%109%11%93%%%19.3%150%FY21FY23FY26
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Base-effect spikes shown pinned (▲). A missing point means that reading is not held for the quarter.
the trajectory the stage is read from · revenue stabilising, profit accelerating
RevenueProfitEPS
27%318%23%252%18%185%13%119%8.5%52%%%15.3%200%119.5%Jun 23Sep 24Apr 26
27%318%23%252%18%185%13%119%8.5%52%%%15.3%200%119.5%Jun 23Sep 24Apr 26
ROCE Trailing-twelve-month operating profit (before interest and tax) as a share of average capital employed — total assets minus current liabilities, the standard textbook basis, %.
the return curve, computed quarterly
ROCE
14%10%6.5%2.8%−1.0%%11%Jun 23Dec 23Sep 24Jul 25Apr 26
14%10%6.5%2.8%−1.0%%11%Jun 23Sep 24Apr 26
Revenue growth
Steady high
latest +15.3% · span +9.8% to +26.1%
EPS growth
Rising
latest +119.5% · span +70.6% to +1,437.5%
ROCE
Stuck low
latest 11.0% · span 0.0%–13.1%

Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.

A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; stock price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Revenue+10.1%+14.2%
Profit+71.0%
EPS+63.4%
Stock price−8.9%
Revenue YoY (Apr 26)
+6.7%
latest quarter vs a year ago
Revenue 10y
14.2%
long-run compound pace
04 · 4-Factor Sector Score

4-Factor Sector Score

37.7/100 — rank 30 of 30 in Engineering & Construction · 50% evidence confidence · provisional, ranked below fully-evidenced peers

Willdan Group, Inc. scores 37.7 out of 100 against the 30 companies it is compared with in Engineering & Construction, ranking 30. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 15.4 + 7.2 + 11.1 + 4 = 37.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Willdan Group, Inc. reported $0.2 B of revenue in the Apr 26 quarter, +6.7% year on year. Over 5 years it has compounded at 14.2% a year. The last full year, FY26, came in at $0.7 B. The last four reported quarters add to $0.7 B.

FY26 revenue came in at $0.7 B (+19.3% on the year), capping 5 years at 14.2% compound. The latest quarter (Apr 26) printed $0.2 B, +6.7% year on year.

FY26 revenue $0.7 B (+19.3% YoY) Revenue bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
14.2% a year over 5 years
RevenueYoY growth
0.724%0.621%0.417%0.214%0.011%$ B%$1B19.3%FY21FY23FY26
0.724%0.621%0.417%0.214%0.011%$ B%$1B19.3%FY21FY23FY26
Apr 26: $0.2 B (+6.7% YoY) Quarterly revenue bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
0.1950%0.1533%0.1017%0.050.0%0.00−17%$ B%$0B6.7%Jun 23Sep 24Apr 26
0.1950%0.1533%0.1017%0.050.0%0.00−17%$ B%$0B6.7%Jun 23Sep 24Apr 26

Pace check: the last four quarters averaged +13.5% growth against the decade's 14.2% — the current year is running in line with its own long-run rate.

Acceleration check: trailing-twelve-month revenue grew +15.3% over the last 4 quarters against +13.3%/yr over the last 8 — stabilising; TTM profit +200.0% vs +144.9%/yr — accelerating.

06 · Operating margin

Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Willdan Group, Inc.'s operating margin is 6.3% in the Apr 26 quarter, −0.4 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 5 fiscal years the operating margin has ranged −2.9% to 5.9%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 6.3%, −0.4 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −2.9%–5.9%, and FY26's 5.9% is the top of that band — a record year.

🚨 Why the margin moved: operating margin went −0.4 pp year on year while gross margin went −2.5 pp — the loss came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

FY26: 5.9% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 5-year window.
the widest a −2.9–5.9% band over 5 years
operating marginYoY change (pp)
6.6%6.6%4.1%5.0%1.5%3.4%−1.1%1.8%−3.6%0.2%%%5.9%0.6%FY21FY23FY26
6.6%6.6%4.1%5.0%1.5%3.4%−1.1%1.8%−3.6%0.2%%%5.9%0.6%FY21FY23FY26
Apr 26: 6.3% operating margin (−0.4 pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
9.0%11%6.6%7.6%4.2%4.2%1.7%0.8%−0.7%−2.5%%%6.3%−0.4%Jun 23Sep 24Apr 26
9.0%11%6.6%7.6%4.2%4.2%1.7%0.8%−0.7%−2.5%%%6.3%−0.4%Jun 23Sep 24Apr 26
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Willdan Group, Inc. earned $0.0 B of net profit in the Apr 26 quarter. Full-year FY26 profit was $0.1 B. That is 6.3% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.

Apr 26 profit was $0.0 B, null year on year. On the full year, FY26 printed $0.1 B (+150.0%).

FY26 profit $0.1 B (+150.0% YoY) Net profit bars, $ B (left); YoY growth-% line (right). 5-year window. A bar is red when it is lower than the year before.
Net profitYoY growth
0.05154%0.04140%0.02125%0.00111%−0.0196%$ B%$0B150%FY21FY23FY26
0.05154%0.04140%0.02125%0.00111%−0.0196%$ B%$0B150%FY21FY23FY26
Apr 26: $0.0 B (null YoY) Quarterly net profit bars, $ B (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
0.0221.2%0.0160.6%0.0110.0%0.005−0.6%0.000−1.2%$ B%$0B0%Jun 23Sep 24Apr 26
0.0221.2%0.0160.6%0.0110.0%0.005−0.6%0.000−1.2%$ B%$0B0%Jun 23Sep 24Apr 26
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 238% of Willdan Group, Inc.'s reported profit arrived as operating cash — the cash follows the profit. In FY26 that was $0.1 B of operating cash against $0.1 B of profit. After $0.0 B of capital spending, $0.1 B was left as free cash.

FY26: operating cash of $0.1 B against reported profit of $0.1 B, leaving free cash of $0.1 B after $0.0 B of capital spending. Across the last 3 fiscal years the conversion rate is 238% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY26: CFO $0.1 B vs profit $0.1 B Operating cash flow and net profit by fiscal year, $ B; the line is free cash flow (CFO minus capital spending). 5-year window, annual resolution.
238% of 3-year profit arrived as cash
Operating cashNet profitFree cash
0.090.060.040.01−0.02$ B$0B$0B$0BFY21FY23FY26
0.090.060.040.01−0.02$ B$0B$0B$0BFY21FY23FY26
Apr 26: operating cash $−0.0 B = −200% of the quarter's profit Operating cash per quarter, $ B (bars); conversion = operating cash as % of net profit (line, right). Last 12 quarters. Dashed line = 100%.
Operating cash (quarterly)Conversion100%
0.04340%0.03195%0.0150%−0.01−95%−0.02−240%$ B%$0B−200%Jun 23Sep 24Apr 26
0.04340%0.03195%0.0150%−0.01−95%−0.02−240%$ B%$0B−200%Jun 23Sep 24Apr 26

Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.

Router verdict: the visible cash user is investment — the next section checks what the spending is buying.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Willdan Group, Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY26 revenue a year.

Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.

On the investment side: capital spending of $0.0 B over the last 3 fiscal years.

FY26: capex $0.0 B Capital spending per fiscal year, $ B (bars).
steady investment
Capex
0.0110.0080.0050.0030.000$ B$0BFY21FY23FY26
0.0110.0080.0050.0030.000$ B$0BFY21FY23FY26
Apr 26: capex $0.0 B in the quarter Capital spending per quarter, $ B (bars, left); free cash flow, $ B (line, right). Last 12 quarters.
Capex (quarterly)Free cash
1.20.050.60.030.00.01−0.6−0.02−1.2−0.04$ B$ B$0B$0BJun 23Sep 24Apr 26
1.20.050.60.030.00.01−0.6−0.02−1.2−0.04$ B$ B$0B$0BJun 23Sep 24Apr 26

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

10 · Return on equity

Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.

Willdan Group, Inc. earns a ROE of 17% in FY26. That is up from a trough of −6% in FY21. Return on invested capital clears the cost of that capital by +3.2 percentage points, so growth here adds value rather than only size. The wiring behind it is 7.4% net margin on 1.26× asset turns.

FY26 ROE is 17%, recovered from a FY21 trough of −6% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY26): 7.4% net margin × 1.26× asset turns × 1.80× balance-sheet leverage ≈ 16.8% on equity. Margin does its share; leverage is a meaningful part of the equation.

The capstone test — ROIC − WACC: 13.5% − 10.3% = a +3.2 pp spread. The 10.3% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

FY26: ROE 17% Return on equity by fiscal year, % (line); ROIC by fiscal year, % (line). 5-year window, dips included. Dashed line = the 10.3% cost of capital used on this page.
the climb back from FY21's −6%
ROEROIC (annual)WACC
22%15%7.3%0.0%−7.7%%16.7%20.1%FY21FY23FY26
22%15%7.3%0.0%−7.7%%16.7%20.1%FY21FY23FY26
Apr 26: ROIC 19.0% (TTM) vs WACC 10.3% Trailing-twelve-month ROIC and ROE, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROIC (TTM)ROE (TTM)WACC
24%17%11%5.0%−1.2%%19%21.8%Jun 23Sep 24Apr 26
24%17%11%5.0%−1.2%%19%21.8%Jun 23Sep 24Apr 26
11 · Dividend

Dividend

Willdan Group, Inc. pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.

Willdan Group, Inc. does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.

12 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.

Willdan Group, Inc. carries total debt of $0.1 B against shareholder equity of $0.3 B as of Apr 26, a debt-to-equity of 0.23 — effectively unlevered. On the annual view that ratio went from 0.67 in FY21 to 0.23 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Apr 26: total debt of $0.1 B against shareholder equity of $0.3 B — a debt-to-equity of 0.23. On the annual view, debt-to-equity went from 0.67 (FY21) to 0.23 (FY26). The returns on this page are earned, not borrowed.

FY26: debt $0.1 B at 0.23× equity Total debt by fiscal year, $ B (bars); debt-to-equity, × (line). 5-year window.
Total debtDebt-to-equity
0.130.7×0.100.6×0.060.5×0.030.3×0.000.2×$ B×$0B0.23×FY21FY23FY26
0.130.7×0.100.6×0.060.5×0.030.3×0.000.2×$ B×$0B0.23×FY21FY23FY26
Apr 26: debt $0.1 B, debt-to-equity 0.23 Total debt per quarter, $ B (bars); debt-to-equity, × (line). Last 12 quarters.
Total debt (quarterly)Debt-to-equity
0.130.7×0.100.5×0.060.4×0.030.3×0.000.2×$ B×$0B0.23×Jun 23Sep 24Apr 26
0.130.7×0.100.5×0.060.4×0.030.3×0.000.2×$ B×$0B0.23×Jun 23Sep 24Apr 26
13 · Ownership

Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.

14.4% of Willdan Group, Inc.'s tradable float is currently sold short — a large bloc is positioned against it. At typical trading volumes those positions would take about 5.1 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.

The latest reading: 14.4% of the float is sold short, and at typical trading volumes it would take about 5.1 days to buy those positions back. A large bloc is positioned against it. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.

Short interest
14.4%
of the tradable float
Days to cover
5.1
at typical volumes

Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.

14 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Willdan Group, Inc.: the Z-score reads 5.92. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 5.92 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 5.92.

15 · Related companies · Engineering & Construction
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Argan, Inc.AGX 69.3/100Favorable setup81% evidence ASLEEP 26.6/35 Revenue 14.5% · PAT 61% · OPM change 3 pp 83% evidence 16.1/25 ROCE 10.5% · OPM 15.6% 76% evidence 12.3/20 P/E 58.9× · PEG 0.99 65% evidence 14.3/20 RS sector 24.9% · RS bench 25.1% · 1Y 158.4%7 of 12 weeks ahead 100% evidence
Exact sum: 26.6 + 16.1 + 12.3 + 14.3 = 69.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
2Comfort Systems USA, Inc.FIX 66.8/100Thin evidence · provisional56% evidence ASLEEP 23.6/35 Revenue — · PAT — · OPM change 5.6 pp 39% evidence 20.1/25 ROCE 18.3% · OPM 17% 76% evidence 9.3/20 P/E 48.8× · PEG — 15% evidence 13.8/20 RS sector 24.3% · RS bench 25% · 1Y 156.7%7 of 12 weeks ahead 100% evidence
Exact sum: 23.6 + 20.1 + 9.3 + 13.8 = 66.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
3IES Holdings, Inc.IESC 65.9/100Thin evidence · provisional53% evidence LEADER 19.7/35 Revenue — · PAT — · OPM change 1.2 pp 32% evidence 17.1/25 ROCE 15.8% · OPM 11.2% 76% evidence 10.2/20 P/E 32.6× · PEG — 15% evidence 18.9/20 RS sector 36% · RS bench 37.9% · 1Y 119.8%11 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 17.1 + 10.2 + 18.9 = 65.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
4Everus Construction Group, Inc.ECG 64.6/100Mixed-positive evidence66% evidence ASLEEP 22.5/35 Revenue 29.7% · PAT 46.7% · OPM change 1.3 pp 53% evidence 13.8/25 ROCE 8.4% · OPM 7.5% 57% evidence 15.2/20 P/E 27.1× · PEG 0.58 65% evidence 13.1/20 RS sector 10.4% · RS bench 11.9% · 1Y 90.6%6 of 12 weeks ahead 100% evidence
Exact sum: 22.5 + 13.8 + 15.2 + 13.1 = 64.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
5Sterling Infrastructure, Inc.STRL 62.8/100Mixed-positive evidence66% evidence FADING 24.3/35 Revenue 36.9% · PAT 32.5% · OPM change 3.7 pp 53% evidence 15.4/25 ROCE 9.3% · OPM 16.7% 57% evidence 11.8/20 P/E 36.4× · PEG 1.19 65% evidence 11.3/20 RS sector 4.4% · RS bench 5.1% · 1Y 78.9%11 of 12 weeks ahead 100% evidence
Exact sum: 24.3 + 15.4 + 11.8 + 11.3 = 62.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Dycom Industries, Inc.DY 57.5/100Mixed-positive evidence81% evidence ASLEEP 22.2/35 Revenue 29.8% · PAT 34.2% · OPM change 0.5 pp 83% evidence 11.9/25 ROCE 3.8% · OPM 7.3% 76% evidence 11.1/20 P/E 41.3× · PEG 1.24 65% evidence 12.3/20 RS sector 1.1% · RS bench 2.9% · 1Y 48.7%6 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 11.9 + 11.1 + 12.3 = 57.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
7EMCOR Group, Inc.EME 56.8/100Thin evidence · provisional56% evidence ASLEEP 19.6/35 Revenue — · PAT — · OPM change 0.5 pp 39% evidence 16.4/25 ROCE 12.2% · OPM 8.7% 76% evidence 10.7/20 P/E 25.8× · PEG — 15% evidence 10.1/20 RS sector -0.3% · RS bench 1.9% · 1Y 32.6%1 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 16.4 + 10.7 + 10.1 = 56.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
8MYR Group Inc.MYRG 56.3/100Thin evidence · provisional56% evidence FADING 21.9/35 Revenue — · PAT — · OPM change 2.4 pp 39% evidence 12.6/25 ROCE 7.9% · OPM 6.5% 76% evidence 9.5/20 P/E 47.5× · PEG — 15% evidence 12.3/20 RS sector 5.8% · RS bench 6.6% · 1Y 83.9%10 of 12 weeks ahead 100% evidence
Exact sum: 21.9 + 12.6 + 9.5 + 12.3 = 56.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
9Arcosa, Inc.ACA 55.2/100Mixed-positive evidence66% evidence BREAKING OUT 19.6/35 Revenue 12.1% · PAT 100% · OPM change 0.7 pp 53% evidence 9.3/25 ROCE 1.1% · OPM 8.2% 57% evidence 8.5/20 P/E 23.4× · PEG 2.09 65% evidence 17.8/20 RS sector 12% · RS bench 14.7% · 1Y 51.4%10 of 12 weeks ahead 100% evidence
Exact sum: 19.6 + 9.3 + 8.5 + 17.8 = 55.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Tetra Tech, Inc.TTEK 55.2/100Thin evidence · provisional56% evidence TURNING 19.1/35 Revenue — · PAT — · OPM change 7.8 pp 39% evidence 13.9/25 ROCE 5.2% · OPM 10.8% 76% evidence 11.3/20 P/E 17.6× · PEG — 15% evidence 10.9/20 RS sector -8.7% · RS bench -5.4% · 1Y -5%1 of 12 weeks ahead 100% evidence
Exact sum: 19.1 + 13.9 + 11.3 + 10.9 = 55.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
11Quanta Services, Inc.PWR 54.8/100Thin evidence · provisional56% evidence ASLEEP 19.9/35 Revenue — · PAT — · OPM change 0.5 pp 39% evidence 11.6/25 ROCE 4.4% · OPM 4.3% 76% evidence 8.8/20 P/E 82.5× · PEG — 15% evidence 14.5/20 RS sector 15.7% · RS bench 17.3% · 1Y 79.5%7 of 12 weeks ahead 100% evidence
Exact sum: 19.9 + 11.6 + 8.8 + 14.5 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
12Exponent, Inc.EXPO 51.5/100Thin evidence · provisional56% evidence TURNING 17.8/35 Revenue — · PAT — · OPM change -5.6 pp 39% evidence 15.0/25 ROCE 5% · OPM 24.9% 76% evidence 10.5/20 P/E 27.3× · PEG — 15% evidence 8.2/20 RS sector -13.2% · RS bench -10.1% · 1Y -4%1 of 12 weeks ahead 100% evidence
Exact sum: 17.8 + 15 + 10.5 + 8.2 = 51.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
13Tutor Perini CorporationTPC 49.6/100Thin evidence · provisional51% evidence ASLEEP 16.5/35 Revenue 25.6% · PAT — · OPM change -0.9 pp 40% evidence 8.2/25 ROCE 3.2% · OPM 4.3% 57% evidence 9.2/20 P/E 52.5× · PEG — 15% evidence 15.7/20 RS sector 3.6% · RS bench 6% · 1Y 51.9%0 of 12 weeks ahead 100% evidence
Exact sum: 16.5 + 8.2 + 9.2 + 15.7 = 49.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
14Cadeler A/SCDLR 48.8/100Mixed-negative evidence66% evidence ASLEEP 19.7/35 Revenue 100% · PAT 100% · OPM change -1.2 pp 53% evidence 7.7/25 ROCE 0.3% · OPM 6.2% 57% evidence 16.5/20 P/E 6.6× · PEG 0.11 65% evidence 4.9/20 RS sector -10.4% · RS bench -8.4% · 1Y 8.5%0 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 7.7 + 16.5 + 4.9 = 48.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Stantec Inc.STN 47.1/100Mixed-negative evidence66% evidence BASING 17.6/35 Revenue 7.6% · PAT 27.6% · OPM change 0.4 pp 53% evidence 11.4/25 ROCE 3.1% · OPM 8.3% 57% evidence 13.1/20 P/E 28× · PEG 1.01 65% evidence 5.0/20 RS sector -32.4% · RS bench -29.6% · 1Y -33.8%0 of 12 weeks ahead 100% evidence
Exact sum: 17.6 + 11.4 + 13.1 + 5 = 47.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16AECOMACM 44.9/100Mixed-negative evidence66% evidence BASING 12.8/35 Revenue -0.4% · PAT 2.6% · OPM change -0.3 pp 53% evidence 11.4/25 ROCE 4.2% · OPM 6.5% 57% evidence 15.3/20 P/E 22.1× · PEG 0.73 65% evidence 5.4/20 RS sector -33.9% · RS bench -30.7% · 1Y -36%0 of 12 weeks ahead 100% evidence
Exact sum: 12.8 + 11.4 + 15.3 + 5.4 = 44.9 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity.
17APi Group CorporationAPG 44.7/100Thin evidence · provisional56% evidence ASLEEP 18.0/35 Revenue — · PAT — · OPM change 0.3 pp 39% evidence 8.9/25 ROCE 2.5% · OPM 5.2% 76% evidence 8.7/20 P/E 95.5× · PEG — 15% evidence 9.1/20 RS sector -9.1% · RS bench -6.8% · 1Y 20.5%0 of 12 weeks ahead 100% evidence
Exact sum: 18 + 8.9 + 8.7 + 9.1 = 44.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
18Fluor CorporationFLR 43.3/100Thin evidence · provisional56% evidence TURNING 11.8/35 Revenue -8.3% · PAT -422.2% · OPM change 0.2 pp 53% evidence 7.4/25 ROCE 1.8% · OPM 2.5% 57% evidence 10.8/20 P/E 25.4× · PEG — 15% evidence 13.3/20 RS sector -2.1% · RS bench 0.5% · 1Y 23%2 of 12 weeks ahead 100% evidence
Exact sum: 11.8 + 7.4 + 10.8 + 13.3 = 43.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
19KBR, Inc.KBR 43.1/100Thin evidence · provisional56% evidence TURNING 14.1/35 Revenue — · PAT — · OPM change -0.6 pp 39% evidence 10.3/25 ROCE 3.5% · OPM 9.4% 76% evidence 11.4/20 P/E 10.9× · PEG — 15% evidence 7.3/20 RS sector -20% · RS bench -16.8% · 1Y -24.2%1 of 12 weeks ahead 100% evidence
Exact sum: 14.1 + 10.3 + 11.4 + 7.3 = 43.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
20Granite Construction IncorporatedGVA 42.8/100Thin evidence · provisional56% evidence ASLEEP 18.8/35 Revenue — · PAT — · OPM change 2.3 pp 39% evidence 9.2/25 ROCE 5.8% · OPM -3.4% 76% evidence 10.1/20 P/E 34.5× · PEG — 15% evidence 4.7/20 RS sector -11.4% · RS bench -9.3% · 1Y 15.2%3 of 12 weeks ahead 100% evidence
Exact sum: 18.8 + 9.2 + 10.1 + 4.7 = 42.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
21MasTec, Inc.MTZ 40.3/100Thin evidence · provisional56% evidence ASLEEP 19.8/35 Revenue — · PAT — · OPM change 2.4 pp 39% evidence 8.4/25 ROCE 3.4% · OPM 3.7% 76% evidence 9.0/20 P/E 66.4× · PEG — 15% evidence 3.1/20 RS sector -12% · RS bench -11.1% · 1Y 49.9%6 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 8.4 + 9 + 3.1 = 40.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
22Construction Partners, Inc.ROAD 39.3/100Mixed-negative evidence66% evidence BASING 19.8/35 Revenue 48.7% · PAT 100% · OPM change 0.1 pp 53% evidence 8.3/25 ROCE 1.5% · OPM 4.9% 57% evidence 8.2/20 P/E 48.7× · PEG 1.79 65% evidence 3.0/20 RS sector -20% · RS bench -17.5% · 1Y -4.9%0 of 12 weeks ahead 100% evidence
Exact sum: 19.8 + 8.3 + 8.2 + 3 = 39.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Ameresco, Inc.AMRC 37.0/100Thin evidence · provisional55% evidence ASLEEP 14.5/35 Revenue 8.5% · PAT -9.3% · OPM change -1.3 pp 40% evidence 7.2/25 ROCE 0.3% · OPM 2.6% 57% evidence 9.9/20 P/E 44× · PEG 1.49 65% evidence 5.4/20 RS sector -19.2% · RS bench -16.4% · 1Y 38.9%1 of 12 weeks ahead 70% evidence
Exact sum: 14.5 + 7.2 + 9.9 + 5.4 = 37 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
24Jacobs Solutions Inc.J 35.2/100Mixed-negative evidence66% evidence TURNING 11.3/35 Revenue 12.7% · PAT -9.3% · OPM change -9.4 pp 53% evidence 6.8/25 ROCE -1% · OPM -2.2% 57% evidence 6.9/20 P/E 38.7× · PEG 2.2 65% evidence 10.2/20 RS sector -9.7% · RS bench -6.3% · 1Y -3.7%1 of 12 weeks ahead 100% evidence
Exact sum: 11.3 + 6.8 + 6.9 + 10.2 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25TopBuild Corp.BLD 35.2/100Thin evidence · provisional60% evidence 11.8/35 Revenue 6.4% · PAT -15.2% · OPM change -2.3 pp 53% evidence 12.8/25 ROCE 3.6% · OPM 12.1% 57% evidence 6.3/20 P/E 19.7× · PEG 2.97 65% evidence 4.3/20 RS sector -30% · RS bench -23.4% · 1Y 2%2 of 7 weeks ahead to 2026-07-02 70% evidence
Exact sum: 11.8 + 12.8 + 6.3 + 4.3 = 35.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
26Primoris Services CorporationPRIM 34.3/100Adverse evidence66% evidence BASING 13.9/35 Revenue 13.4% · PAT 20.4% · OPM change -2.7 pp 53% evidence 7.9/25 ROCE 1% · OPM 1.6% 57% evidence 10.0/20 P/E 31.5× · PEG 1.57 65% evidence 2.5/20 RS sector -38.4% · RS bench -36.6% · 1Y -18.3%0 of 12 weeks ahead 100% evidence
Exact sum: 13.9 + 7.9 + 10 + 2.5 = 34.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Cardinal Infrastructure Group Inc.CDNL 50.6/100Thin evidence · provisional22% evidence BREAKING OUT 18.6/35 Revenue — · PAT — · OPM change -0.9 pp 15% evidence 13.5/25 ROCE 5.6% · OPM 8.8% 57% evidence 8.5/20 P/E 403× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —12 of 12 weeks ahead 0% evidence
Exact sum: 18.6 + 13.5 + 8.5 + 10 = 50.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
28Ferrovial N.V.FER 44.7/100Thin evidence · provisional43% evidence ASLEEP 18.0/35 Revenue — · PAT — · OPM change — 12% evidence 9.8/25 ROCE 1.3% · OPM — 61% evidence 8.9/20 P/E 71.4× · PEG — 15% evidence 8.0/20 RS sector -10.6% · RS bench -8.2% · 1Y 26.7%0 of 12 weeks ahead 100% evidence
Exact sum: 18 + 9.8 + 8.9 + 8 = 44.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
29Legence Corp.LGN 40.8/100Thin evidence · provisional31% evidence ASLEEP 15.7/35 Revenue 44.3% · PAT 13.3% · OPM change -1.1 pp 40% evidence 6.5/25 ROCE 1.1% · OPM 2.2% 57% evidence 8.6/20 P/E 192.6× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —8 of 12 weeks ahead 0% evidence
Exact sum: 15.7 + 6.5 + 8.6 + 10 = 40.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30Willdan Group, Inc.this pageWLDN 37.7/100Thin evidence · provisional50% evidence BASING 15.4/35 Revenue — · PAT — · OPM change 0.1 pp 39% evidence 7.2/25 ROCE 2% · OPM 4.7% 76% evidence 11.1/20 P/E 21.7× · PEG — 15% evidence 4.0/20 RS sector -30.8% · RS bench -28.1% · 1Y -32.7%2 of 12 weeks ahead 70% evidence
Exact sum: 15.4 + 7.2 + 11.1 + 4 = 37.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

16 · Frequently asked questions

Frequently asked questions

What is Willdan Group, Inc.'s stock price today?

Willdan Group, Inc. trades at $76.5, −8.9% over the past year. The company is valued at $1.0 B. The stock sits at 12% of its 52-week range of $69–$134, −18.4% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 7 weeks. — as of 5 August 2026.

What were Willdan Group, Inc.'s latest quarterly results?

Willdan Group, Inc. reported revenue of $0.2 B and net profit of $0.0 B for the Apr 26 quarter. Earnings per share were $0.55. The operating margin was 6.3%, 0.4 pp lower than a year earlier. — as of 5 August 2026.

What is Willdan Group, Inc.'s revenue?

Willdan Group, Inc. reported revenue of $0.2 B in the Apr 26 quarter, +6.7% year on year. For the full FY26 fiscal year, revenue was $0.7 B (+19.3%). Over the last 5 years revenue compounded at 14.2% a year. — as of 5 August 2026.

What is Willdan Group, Inc.'s profit?

Willdan Group, Inc. earned $0.0 B of net profit in the Apr 26 quarter. Full-year FY26 profit was $0.1 B. The operating margin ran 6.3% in the latest quarter. — as of 5 August 2026.

What is Willdan Group, Inc.'s market cap?

Willdan Group, Inc.'s market capitalisation is $1.0 B at a stock price of $76.5. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.

What is Willdan Group, Inc.'s P/E ratio?

Willdan Group, Inc. trades at a P/E of 20.7×, at the 12th percentile of its own 1-year range, against a long-run median of 32.8×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.

Does Willdan Group, Inc. pay a dividend?

No — Willdan Group, Inc. has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.

Is Willdan Group, Inc. overvalued?

On its own history, Willdan Group, Inc. looks cheap against its own history: its P/E of 20.7× has been cheaper only 12% of the time in 1 years (long-run median 32.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. One caveat: margins are the best this company has ever printed — cheap on record margins is not the same thing as cheap. — as of 5 August 2026.

How is Willdan Group, Inc. performing?

Willdan Group, Inc.'s latest readings are below. Against the S&P 500 it has been behind on a trailing-13-week view for 7 weeks. This describes what the data did, not a rating. — as of 5 August 2026.

What stage is Willdan Group, Inc. in?

Mixed — the growth curves are steadily positive, but ROCE at 11.0% is below the 15% bar this page requires to call it Consistent. The read comes from the last 12 quarters of growth (revenue growth +15.3% latest, eps growth +119.5% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.

Is Willdan Group, Inc. beating the market?

Not lately — on a trailing-13-week view Willdan Group, Inc. is currently behind the S&P 500 (7 weeks and counting; last ahead the week of 2026-06-18), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved +4% against the S&P 500's +24% — behind the index over the full window. — as of 5 August 2026.

Will Willdan Group, Inc.'s stock price go up?

This page publishes no price forecast for Willdan Group, Inc. What it measures instead: the stock price is $76.5. Its P/E of 20.7× sits at the 12th percentile of its own 1-year range. Direction is not something this site claims to know. — as of 5 August 2026.

Is the market betting against Willdan Group, Inc.?

Yes — short interest is 14.4% of Willdan Group, Inc.'s tradable float, about 5.1 days to cover at typical volumes. A crowded short: a large bloc is positioned against it. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.

Does Willdan Group, Inc. have too much debt?

No — Willdan Group, Inc.'s debt-to-equity is 0.22. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. The returns on this page are earned, not borrowed — as of 5 August 2026.

What is Willdan Group, Inc.'s capex?

Willdan Group, Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was $0.0 B. — as of 5 August 2026.

What is Willdan Group, Inc.'s cash flow?

Willdan Group, Inc. generated $0.1 B of operating cash flow in FY26 and $0.1 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.1 B, so operating cash ran ahead of profit. — as of 5 August 2026.

Is Willdan Group, Inc.'s profit real cash?

Yes — over the last 3 fiscal years, 238% of Willdan Group, Inc.'s reported profit arrived as operating cash. In FY26, operating cash was $0.1 B against reported profit of $0.1 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.

How financially safe is Willdan Group, Inc.?

On the balance sheet, the Z-score reads 5.92 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.

Where is Willdan Group, Inc. in its business cycle?

Willdan Group, Inc.'s FY26 operating margin was 5.9%, against a 5-year band of −2.9%–5.9%: the top of the band — a record year. Record profitability is late-cycle territory: every ratio flatters at the top, and the story leans on margins holding. The latest quarter ran 6.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.

What could break the Willdan Group, Inc. story?

The sharpest disagreement: annual EPS moved +120.9% against a −8.9% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.

Is Willdan Group, Inc. a stock worth studying right now?

This is not investment advice. The machine read: Willdan Group, Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI